Page last updated: 2024-10-31

nafamostat and Angiospasm, Intracranial

nafamostat has been researched along with Angiospasm, Intracranial in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Research Excerpts

ExcerptRelevanceReference
"To evaluate the development of cerebral vasospasm, the caliber of the basilar artery was measured on x-ray film before and at 2 days after SAH."1.31Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB. ( Kikuchi, H; Nagata, I; Sakai, H; Sakai, N; Xue, JH; Yanamoto, H; Zhang, Z, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, Z1
Nagata, I1
Kikuchi, H1
Xue, JH1
Sakai, N1
Sakai, H1
Yanamoto, H1

Other Studies

1 other study available for nafamostat and Angiospasm, Intracranial

ArticleYear
Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB.
    Stroke, 2001, Volume: 32, Issue:7

    Topics: Animals; Antithrombins; Arginine; Becaplermin; Benzamidines; Cerebral Arteries; Cisterna Magna; Guan

2001